When orphan drugs are blockbusters: Researchers call on Congress to make companies pay back tax credits
A new research letter published today in JAMA questions whether there needs to be continued orphan drug incentives considering the spike in the number of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
